바이러스 여과는 동물세포기반 바이오 의약품 제조에서 중요한 정제 공정으로, 특수하게 설계 및 제조된 분리막 을 사용하여 바이러스를 차단하고 항체 등 바이오 의약 물질을 선택적으로 통과시킨다. 바이러스 필터의 핵심 성능인 바이러 스 제거율과 항체 및 단백질의 회수율은 필터의 기공 구조와 대칭성뿐만 아니라, 여과 조건(표면 다공성, 압력, 유속, pH, 이 온 강도 등)에 따라 달라진다. 특히 단백질 오염은 비가역적 및 가역적 오염으로 구분되며, 추가로 blocking 모델을 통해 정밀 하게 분석하였다. 본 총설에서는 바이러스 필터 및 여과 공정의 이해 및 최적화를 위해 필터 구조, 제거 기작과 막오염 현상 을 소개하고, 바이러스 여과 공정에서 제거성능에 영향을 미치는 다양한 인자를 분석해보고자 한다.

This study was undertaken to investigate whether HEPA filter-equipped air purifiers can remove aerosolized virus, whether the removed virus can re-scatter through the filter, and how long the removed virus keeps its infectivity in the filter. For this investigation, six HEPA filter-equipped air purifiers produced by different companies were tested against PhiX174 and MS2 phages aerosolized by nebulizers. For viral detection from the air, LB agar plates covered with Escherichia coli hosts and an Andersen air sampler were used, and from the surface, the swab method was used. Both the aerosolized PhiX174 and MS2 viruses absorbed by the HEPA filters in the air purifiers were not detected from the air through filters or the surface of the outlet of the air purifiers. During the operation of the air purifiers at medium mode, the infectious viral concentration of these viruses in the HEPA filters decreased to 0%~12.3% as the time period passed. These results regarding infectious viral concentration differences were assumed to be due to the different wind speed and air volume among the six air purifiers. Based on observations over 5 days, the infectious viral concentration of the PhiX174 phage was 8,600 times lower when the air purifier was operated than when it was not operated. Overall, our results demonstrate that HEPA filter-equipped air purifiers can efficiently remove the two aerosolized viruses and the removed viruses in the HEPA filter could not re-spread and maintain their infectivity.